This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
virus infection | 276 |
infected cells | 235 |
united states | 201 |
respiratory tract | 192 |
respiratory syndrome | 164 |
acute respiratory | 153 |
type i | 147 |
influenza virus | 146 |
respiratory viruses | 140 |
viral infection | 132 |
amino acid | 131 |
viral rna | 128 |
respiratory syncytial | 128 |
mycoplasma pneumoniae | 125 |
immune response | 121 |
viral infections | 119 |
antibiotic resistance | 119 |
host cell | 118 |
syncytial virus | 118 |
rna viruses | 115 |
virus replication | 110 |
endoplasmic reticulum | 107 |
viral replication | 107 |
filamentous phage | 105 |
immune responses | 100 |
zika virus | 99 |
dengue virus | 96 |
epithelial cells | 95 |
antimicrobial peptides | 94 |
core protein | 93 |
host cells | 92 |
lower respiratory | 91 |
innate immune | 91 |
front microbiol | 89 |
cord uid | 89 |
microbiol doi | 89 |
doc id | 89 |
ms plp | 88 |
stem cell | 83 |
membrane fusion | 83 |
vero cells | 82 |
hcv core | 82 |
gene expression | 82 |
severe acute | 82 |
cell culture | 80 |
antiviral activity | 80 |
tract infections | 77 |
cell lines | 76 |
i ifn | 76 |
respiratory viral | 76 |
time pcr | 75 |
nucleic acid | 75 |
respiratory virus | 72 |
amino acids | 72 |
virus infections | 72 |
immune system | 71 |
capsid protein | 71 |
cell transplant | 70 |
syndrome virus | 69 |
measles virus | 69 |
signaling pathway | 68 |
human metapneumovirus | 67 |
porcine epidemic | 67 |
cell line | 66 |
supplementary table | 66 |
infectious diseases | 65 |
signaling pathways | 65 |
performed using | 64 |
strain srs | 64 |
transplant recipients | 64 |
porcine reproductive | 64 |
syndrome coronavirus | 63 |
viral proteins | 63 |
hela cells | 62 |
zikv infection | 62 |
epidemic diarrhea | 62 |
innate immunity | 62 |
disease virus | 61 |
previously described | 61 |
parainfluenza virus | 61 |
cell transplantation | 61 |
public health | 60 |
life cycle | 60 |
respiratory infections | 60 |
significantly higher | 60 |
cell cycle | 59 |
nlrp inflammasome | 59 |
cell fusion | 59 |
orf protein | 58 |
herpes simplex | 58 |
mg kg | 58 |
genome sequence | 58 |
monoclonal antibody | 57 |
supplementary material | 56 |
er stress | 55 |
diarrhea virus | 55 |
protein expression | 55 |
lipid rafts | 55 |
barr virus | 54 |
risk factors | 54 |
viral entry | 53 |
simplex virus | 53 |
virus type | 53 |
stranded rna | 52 |
present study | 52 |
hematopoietic cell | 52 |
human adenovirus | 51 |
previous studies | 51 |
positively selected | 51 |
hematopoietic stem | 50 |
human rhinovirus | 49 |
expression levels | 49 |
viral protein | 49 |
target cells | 49 |
acquired pneumonia | 49 |
ifn signaling | 48 |
intracellular extracts | 47 |
statistically significant | 47 |
hct recipients | 47 |
results showed | 47 |
cellular proteins | 47 |
respiratory pathogens | 46 |
positive selection | 46 |
host proteins | 46 |
hpv psv | 45 |
viral load | 45 |
cells infected | 45 |
pdcov hnzk | 44 |
swine fever | 44 |
important role | 44 |
antimicrobial peptide | 43 |
clinical samples | 43 |
protein kinase | 43 |
multiplex pcr | 43 |
viral particles | 43 |
viral genome | 43 |
target cell | 43 |
fever virus | 42 |
crystal structure | 42 |
control group | 42 |
cell surface | 41 |
neutralizing antibodies | 41 |
cell membrane | 41 |
ebola virus | 41 |
described previously | 41 |
type iii | 41 |
three times | 41 |
morpholino oligomers | 41 |
structural proteins | 40 |
mammalian cells | 40 |
immunodeficiency virus | 40 |
plasma membrane | 40 |
cells treated | 40 |
phylogenetic analysis | 39 |
genetic diversity | 39 |
mass spectrometry | 39 |
microbiology www | 39 |
selected sites | 39 |
clinical signs | 39 |
mouth disease | 39 |
encephalitis virus | 39 |
reverse transcription | 39 |
binding protein | 38 |
room temperature | 38 |
unfolded protein | 38 |
financial relationships | 38 |
atmuv infection | 38 |
phage display | 38 |
aa identity | 38 |
thermo fisher | 38 |
ifitm proteins | 38 |
growth factor | 38 |
virus entry | 38 |
protein response | 38 |
novel coronavirus | 37 |
segmented filamentous | 37 |
coat protein | 37 |
potential conflict | 37 |
virus core | 37 |
testicular tissue | 37 |
bluefin tuna | 37 |
clinical trials | 37 |
pedv infection | 37 |
cultured cells | 37 |
selective pressure | 36 |
genome sequences | 36 |
pneumoniae infection | 36 |
respiratory infection | 36 |
lung injury | 36 |
human immunodeficiency | 36 |
filamentous bacteria | 36 |
african swine | 36 |
ma sr | 36 |
open reading | 36 |
pcr assay | 35 |
antimicrobial resistance | 35 |
rna virus | 35 |
rna polymerase | 35 |
sgh symptoms | 35 |
found online | 35 |
total rna | 35 |
expressing cells | 35 |
fisher scientific | 35 |
fmdv infection | 35 |
recent study | 35 |
gut microbiota | 35 |
negative control | 35 |
coronavirus disease | 34 |
results suggest | 34 |
viral pathogenesis | 34 |
closely related | 34 |
authors declare | 34 |
induced asthma | 34 |
spike protein | 34 |
dependent manner | 34 |
cell death | 33 |
resistance genes | 33 |
dendritic cells | 33 |
neutralizing antibody | 33 |
cell entry | 33 |
previous study | 33 |
membrane protein | 33 |
heavy metal | 33 |
copy number | 32 |
mrna expression | 32 |
envelope protein | 32 |
whole genome | 32 |
cells via | 32 |
er membrane | 32 |
inflammatory cytokines | 32 |
generation sequencing | 31 |
upper respiratory | 31 |
recent studies | 31 |
sequence analysis | 31 |
eta ds | 31 |
reading frame | 31 |
capsid proteins | 31 |
escherichia coli | 31 |
monoclonal antibodies | 31 |
mcp complex | 30 |
endothelial cells | 30 |
independent experiments | 30 |
three independent | 30 |
antiviral therapy | 30 |
associated degradation | 30 |
rna species | 30 |
adenovirus type | 30 |
western blot | 30 |
transcription factor | 30 |
inflammatory response | 30 |
dna vaccine | 30 |
pdcov infection | 29 |
simultaneous detection | 29 |
animal models | 29 |
original author | 29 |
social norms | 29 |
full supplementary | 29 |
chain reaction | 29 |
rna replication | 29 |
creative commons | 29 |
commons attribution | 29 |
cdv infection | 29 |
polymerase chain | 29 |
respiratory disease | 29 |
attribution license | 29 |
bat species | 29 |
human health | 29 |
original publication | 29 |
rk cells | 29 |
article distributed | 29 |
coding genes | 29 |
sendai virus | 29 |
org articles | 28 |
bovine serum | 28 |
adult patients | 28 |
host immune | 28 |
well plate | 28 |
mediated endocytosis | 28 |
significant differences | 28 |
data analysis | 28 |
porcine circovirus | 28 |
cancer cells | 28 |
may also | 28 |
like lineage | 28 |
accepted academic | 28 |
academic practice | 28 |
western blotting | 28 |
disease severity | 28 |
human respiratory | 28 |
host innate | 28 |
clinical symptoms | 27 |
stress granules | 27 |
goat anti | 27 |
transmembrane protein | 27 |
wild type | 27 |
filamentous bacteriophage | 27 |
lu cells | 27 |
hemorrhagic fever | 27 |
mcp endocytosis | 27 |
hospitalized patients | 27 |
genomic dna | 27 |
antimicrobial activity | 27 |
canine distemper | 27 |
associated herpesvirus | 27 |
systematic review | 27 |
significantly increased | 27 |
luciferase reporter | 27 |
time points | 27 |
vigen pipeline | 27 |
treated mice | 27 |
clinical specimens | 26 |
body sites | 26 |
viral pneumonia | 26 |
i interferon | 26 |
well plates | 26 |
hrv infection | 26 |
pcv replication | 26 |
days post | 26 |
infected mice | 26 |
japanese encephalitis | 26 |
aurintricarboxylic acid | 26 |
transfected cells | 26 |
pneumoniae infections | 26 |
significant difference | 26 |
cell proliferation | 26 |
taken together | 26 |
signal transduction | 26 |
binding site | 26 |
sars coronavirus | 26 |
gel electrophoresis | 25 |
hev infection | 25 |
low ph | 25 |
west nile | 25 |
global health | 25 |
tract infection | 25 |
cell receptor | 25 |
body weight | 25 |
tgev group | 25 |
hr domain | 25 |
rapid detection | 25 |
different types | 25 |
access article | 25 |
streptococcus pneumoniae | 25 |
statistical significance | 25 |
structural protein | 25 |
glycogen synthase | 25 |
large number | 25 |
ppmo targeting | 25 |
better understanding | 25 |
porcine deltacoronavirus | 25 |
stat signaling | 25 |
electron microscopy | 25 |
middle east | 25 |
molecular mechanisms | 25 |
copies ml | 25 |
human papillomavirus | 25 |
isothermal amplification | 25 |
lymphocytic choriomeningitis | 25 |
nile virus | 25 |
viral dna | 25 |
xmap technology | 25 |
cervical cancer | 25 |
data suggest | 24 |
hcv replication | 24 |
stress granule | 24 |
agarose gel | 24 |
hpv infection | 24 |
molecular epidemiology | 24 |
acid residues | 24 |
plasmodium falciparum | 24 |
microbial communities | 24 |
sense rna | 24 |
choriomeningitis virus | 24 |
human coronavirus | 24 |
virus particles | 24 |
one health | 24 |
gut microbiome | 24 |
bal ds | 24 |
pr pbs | 24 |
allogeneic hematopoietic | 23 |
coronavirus infection | 23 |
genome sequencing | 23 |
intensive care | 23 |
also known | 23 |
analyzed using | 23 |
class i | 23 |
previous reports | 23 |
avian influenza | 23 |
immune cells | 23 |
flow cytometry | 23 |
cell types | 23 |
inhibitory activity | 23 |
tissue culture | 23 |
protein synthesis | 23 |
circovirus type | 23 |
nonstructural protein | 23 |
tgev infection | 23 |
east respiratory | 23 |
nucleotide sequences | 23 |
secondary scaffolding | 23 |
phage displaying | 23 |
pbs group | 23 |
heavy metals | 23 |
genomic rna | 23 |
penton base | 22 |
economic losses | 22 |
ns protein | 22 |
enveloped viruses | 22 |
respiratory symptoms | 22 |
least one | 22 |
highly conserved | 22 |
high mannose | 22 |
inflammasome activation | 22 |
chronic pain | 22 |
determined using | 22 |
widely used | 22 |
distemper virus | 22 |
inhibitory effect | 22 |
two groups | 22 |
viral pathogens | 22 |
polyclonal antibody | 22 |
dna replication | 22 |
cancer patients | 22 |
mrna levels | 22 |
inflammatory cytokine | 22 |
differentially expressed | 22 |
polyclonal antibodies | 22 |
synthase kinase | 22 |
positively charged | 22 |
time rt | 22 |
may lead | 22 |
southern bluefin | 22 |
dependent endocytosis | 22 |
virus ns | 22 |
human parainfluenza | 21 |
th cells | 21 |
induced apoptosis | 21 |
way anova | 21 |
rna genome | 21 |
determine whether | 21 |
dependent rna | 21 |
recent years | 21 |
cell viability | 21 |
gs cells | 21 |
commercially available | 21 |
host factor | 21 |
rhinovirus infection | 21 |
mediated isothermal | 21 |
serratia marcescens | 21 |
like receptor | 21 |
bacterial pathogens | 21 |
severe disease | 21 |
nucleic acids | 21 |
infected patients | 21 |
control cells | 21 |
previously reported | 21 |
microbial community | 21 |
fetal bovine | 21 |
world health | 21 |
human igg | 21 |
persistent infection | 21 |
young children | 21 |
vitro prophylactic | 21 |
ion channel | 20 |
viral genomes | 20 |
mg ml | 20 |
copyright owner | 20 |
vesicular stomatitis | 20 |
transmissible gastroenteritis | 20 |
culture supernatants | 20 |
highly pathogenic | 20 |
viral diseases | 20 |
mesenteroides ypk | 20 |
avian leukosis | 20 |
microbial diversity | 20 |
mouse model | 20 |
sequence similarity | 20 |
bacterial infections | 20 |
another study | 20 |
ifn production | 20 |
epithelial cell | 20 |
molecular evolution | 20 |
adaptive immune | 20 |
virus orf | 20 |
final concentration | 20 |
socs expression | 20 |
expression level | 20 |
lactic acid | 20 |
iav infection | 20 |
displaying pep | 20 |
capsid coat | 20 |
statistical analysis | 20 |
health organization | 20 |
leukosis virus | 20 |
severe covid | 20 |
antibody response | 20 |
proteomic analysis | 20 |
hek cells | 19 |
subcellular localization | 19 |
common cold | 19 |
salivary gland | 19 |
blood fluke | 19 |
high levels | 19 |
commonly used | 19 |
caveolae raft | 19 |
significantly reduced | 19 |
stomatitis virus | 19 |
ubiquitin ligase | 19 |
detection rate | 19 |
homologous recombination | 19 |
cells using | 19 |
among different | 19 |
viral titers | 19 |
significantly different | 19 |
protein folding | 19 |
accession number | 19 |
liver cancer | 19 |
also found | 19 |
clinical trial | 19 |
immune evasion | 19 |
macro domain | 19 |
luciferase activity | 19 |
envelope glycoprotein | 19 |
late stage | 19 |
complete genome | 19 |
binding domain | 19 |
reticulum stress | 19 |
associated protein | 19 |
years ago | 19 |
terminal region | 19 |
clinical features | 19 |
assay kit | 19 |
mock group | 19 |
acid bacteria | 18 |
critical role | 18 |
phylogenetic trees | 18 |
like growth | 18 |
fusion protein | 18 |
different time | 18 |
common respiratory | 18 |
igf mrna | 18 |
infected individuals | 18 |
sap mutant | 18 |
mortality rate | 18 |
genome replication | 18 |
viral detection | 18 |
quality control | 18 |
treated cells | 18 |
binding sites | 18 |
psv entry | 18 |
pcr amplification | 18 |
virus detection | 18 |
respiratory distress | 18 |
rabbit polyclonal | 18 |
homing peptide | 18 |
human norovirus | 18 |
nervous system | 18 |
rrna gene | 18 |
receptor binding | 18 |
gastrointestinal tract | 18 |
specific primers | 18 |
antiviral effects | 18 |
pcv infection | 18 |
genotype hev | 18 |
virus envelope | 18 |
among patients | 18 |
also shown | 17 |
infection control | 17 |
initiation factor | 17 |
distress syndrome | 17 |
virus rna | 17 |
viral capsid | 17 |
vaccinia virus | 17 |
reverse transcriptase | 17 |
dna viruses | 17 |
pr infection | 17 |
orf product | 17 |
gsk inhibition | 17 |
infection rate | 17 |
lung tissue | 17 |
rhesus macaques | 17 |
antiviral responses | 17 |
several studies | 17 |
sequence alignment | 17 |
viral envelope | 17 |
day post | 17 |
mosquito cells | 17 |
viral lineages | 17 |
natural ecosystems | 17 |
life technologies | 17 |
induced transmembrane | 17 |
serratia sp | 17 |
nipah virus | 17 |
molecular biology | 17 |
like particles | 17 |
tembusu virus | 17 |
virus capsid | 17 |
multiplex detection | 17 |
causative agent | 17 |
hcv rna | 17 |
publicly available | 17 |
pcr system | 17 |
cholera toxin | 17 |
hev replication | 17 |
pdb id | 17 |
virus nonstructural | 17 |
infectious bronchitis | 17 |
tumor cells | 17 |
ms ms | 17 |
er lumen | 17 |
iso ts | 17 |
viral gene | 17 |
family members | 17 |
human cytomegalovirus | 17 |
host factors | 17 |
antibody responses | 17 |
acid substitutions | 17 |
sequence data | 17 |
drug resistance | 17 |
proteins may | 17 |
expression plasmid | 16 |
protein levels | 16 |
phylogenetic tree | 16 |
gpsghv infection | 16 |
activated protein | 16 |
results obtained | 16 |
kindly provided | 16 |
overt sgh | 16 |
coat proteins | 16 |
pr ppp | 16 |
high risk | 16 |
rubella virus | 16 |
wide range | 16 |
human bocavirus | 16 |
human host | 16 |
current study | 16 |
infectious disease | 16 |
insect cells | 16 |
pathogenic viruses | 16 |
peptides derived | 16 |
misfolded proteins | 16 |
gene transfer | 16 |
interferon production | 16 |
common ancestor | 16 |
results suggested | 16 |
applied biosystems | 16 |
kefir grains | 16 |
bioactive compounds | 16 |
ifitm expression | 16 |
disease control | 16 |
virus release | 16 |
secondary antibody | 16 |
tm system | 16 |
intestinal epithelial | 16 |
different concentrations | 16 |
among children | 16 |
hospitalized children | 16 |
patients infected | 16 |
mutant fmdv | 16 |
denv infection | 16 |
linked immunosorbent | 16 |
molecular epidemiological | 16 |
stranded dna | 16 |
material key | 16 |
also observed | 16 |
xtag rvp | 16 |
pcv orf | 16 |
calculated using | 16 |
mucosal microbiome | 16 |
ge healthcare | 16 |
mapk signaling | 16 |
fusion core | 16 |
cell cultures | 16 |
transmembrane proteins | 16 |
authors contributed | 16 |
seq data | 16 |
comparative analysis | 16 |
coat related | 16 |
hev strains | 16 |
cytokine storm | 16 |
virus strains | 16 |
encephalomyocarditis virus | 16 |
wide variety | 16 |
multiplex assays | 16 |
melanoma cells | 16 |
buffered saline | 15 |
detected using | 15 |
duck ifitm | 15 |
scaff link | 15 |
human coronaviruses | 15 |
fused cells | 15 |
intestinal microbiota | 15 |
pulmonary disease | 15 |
nasopharyngeal carcinoma | 15 |
datasets generated | 15 |
cellular receptor | 15 |
stimulated genes | 15 |
antibacterial activity | 15 |
one study | 15 |
new york | 15 |
human igm | 15 |
nucleolar localization | 15 |
viral respiratory | 15 |
steroid use | 15 |
cell membranes | 15 |
nitric oxide | 15 |
bronchitis virus | 15 |
cell wall | 15 |
sars cov | 15 |
prospective study | 15 |
env protein | 15 |
major capsid | 15 |
tumor mass | 15 |
structural basis | 15 |
target sequence | 15 |
metabolic syndrome | 15 |
gland hypertrophy | 15 |
infection induces | 15 |
overall mortality | 15 |
also identified | 15 |
viral shedding | 15 |
virus adsorption | 15 |
infectious agents | 15 |
hantaan virus | 15 |
genome size | 15 |
igf protein | 15 |
three different | 15 |
associated proteins | 15 |
rsv infection | 15 |
even though | 15 |
egr sirna | 15 |
pediatric patients | 15 |
virus strain | 15 |
disease progression | 15 |
hev genotypes | 15 |
positive samples | 15 |
batcov hku | 15 |
lcmv infection | 15 |
transcriptional activity | 15 |
antibiotic use | 15 |
mm nacl | 15 |
food safety | 15 |
highly effective | 15 |
essential role | 15 |
endophytic fungi | 15 |
gold standard | 15 |
turnaround time | 15 |
severe respiratory | 15 |
graphpad prism | 15 |
bat origin | 15 |
transmembrane domain | 15 |
serratia species | 15 |
sequence identity | 15 |
vp region | 15 |
organ transplant | 15 |
diagnostic methods | 15 |
qpcr detection | 15 |
iseq tm | 15 |
immunosorbent assay | 15 |
mouse igg | 15 |
culture system | 15 |
internal control | 15 |
clinical characteristics | 15 |
may provide | 15 |
antiviral immunity | 15 |
multiple sequence | 15 |
also detected | 15 |
extraction efficiency | 15 |
glycosylation sites | 15 |
infected host | 15 |
analysis showed | 15 |
new insights | 15 |
induced cell | 15 |
insulin resistance | 14 |
antiviral innate | 14 |
asthma exacerbations | 14 |
breast cancer | 14 |
results indicated | 14 |
virion assembly | 14 |
lysis buffer | 14 |
cbdi genomes | 14 |
chronic hepatitis | 14 |
respiratory illness | 14 |
peripheral blood | 14 |
rna extraction | 14 |
infected cell | 14 |
nh cl | 14 |
regulatory factor | 14 |
may cause | 14 |
positive control | 14 |
like receptors | 14 |
cells pretreated | 14 |
important roles | 14 |
hev rna | 14 |
pr igf | 14 |
nucleotide sequence | 14 |
active site | 14 |
incubated overnight | 14 |
treatment group | 14 |
jurkat cells | 14 |
vp protein | 14 |
submitted version | 14 |
enteric rna | 14 |
human cells | 14 |
mm tris | 14 |
medius genome | 14 |
aptamer cy | 14 |
rhesus monkeys | 14 |
resistant bacteria | 14 |
informed consent | 14 |
pseudomonas aeruginosa | 14 |
two different | 14 |
target genes | 14 |
hemorrhagic disease | 14 |
two distinct | 14 |
rna synthesis | 14 |
translation initiation | 14 |
four farms | 14 |
metabolic activity | 14 |
literature review | 14 |
cell apoptosis | 14 |
adenovirus infection | 14 |
quantitative pcr | 14 |
phylogenetic diversity | 14 |
fish species | 14 |
nuclear translocation | 14 |
nuclear localization | 14 |
reactive oxygen | 14 |
antiviral response | 14 |
dna virus | 14 |
cellular processes | 14 |
quantitative real | 14 |
infection induced | 14 |
entry efficiency | 14 |
human adenoviruses | 14 |
converting enzyme | 14 |
host range | 14 |
infected group | 14 |
rna binding | 14 |
viral loads | 14 |
gastroenteritis virus | 14 |
wildtype fmdv | 14 |
antiviral agents | 14 |
study showed | 14 |
cellular uptake | 14 |
mouse anti | 14 |
enrichment analysis | 14 |
kosakovsky pond | 14 |
virus genome | 14 |
tract disease | 14 |
age group | 14 |
pathogenic bacteria | 14 |
pcr analysis | 14 |
dna extraction | 14 |
cytopathic effect | 14 |
nucleocapsid protein | 14 |
virus subgroup | 14 |
viral variants | 13 |
beta diversity | 13 |
fungal pathogens | 13 |
washed three | 13 |
secondary structure | 13 |
inhibitory effects | 13 |
virus titer | 13 |
morpholino oligomer | 13 |
conjugated morpholino | 13 |
respiratory diseases | 13 |
healthy controls | 13 |
respiratory specimens | 13 |
viral genes | 13 |
lassa virus | 13 |
sequencing data | 13 |
proteasomal degradation | 13 |
mesenteroides subsp | 13 |
pzq treatment | 13 |
high prevalence | 13 |
transcription factors | 13 |
unusual viral | 13 |
lr union | 13 |
syncytium formation | 13 |
secondary antibodies | 13 |
health care | 13 |
mrna splicing | 13 |
like protein | 13 |
cells well | 13 |
high throughput | 13 |
ethics committee | 13 |
ng ml | 13 |
genetic analysis | 13 |
analysis revealed | 13 |
cell receptors | 13 |
human herpesvirus | 13 |
akt signaling | 13 |
nuclear antigen | 13 |
infected samples | 13 |
fluorescent signal | 13 |
like protease | 13 |
host cellular | 13 |
hcv genotypes | 13 |
remains unclear | 13 |
antiviral signaling | 13 |
mechanisms underlying | 13 |
innate antiviral | 13 |
mediated antiviral | 13 |
north america | 13 |
also showed | 13 |
animal model | 13 |
cells expressing | 13 |
also called | 13 |
detection probes | 13 |
evolutionary analysis | 13 |
rv species | 13 |
drug delivery | 13 |
rapid diagnosis | 13 |
proteins involved | 13 |
analysis using | 13 |
tsetse fly | 13 |
granule formation | 13 |
long time | 13 |
protein degradation | 13 |
meyer sauteur | 13 |
pcr products | 13 |
norovirus gii | 13 |
regulated proteins | 13 |
cysteine protease | 13 |
hypervariable regions | 13 |
mammalian cell | 13 |
uninfected cells | 13 |
antiviral immune | 13 |
swine industry | 13 |
hydroxyphthalic anhydride | 13 |
infection rates | 13 |
host defense | 13 |
sexual transmission | 13 |
dna polymerase | 13 |
relatively low | 13 |
iii ifns | 13 |
microbiome composition | 13 |
erad substrates | 13 |
human gut | 13 |
empty vector | 13 |
viral infectivity | 13 |
sequence reads | 13 |
genbank accession | 13 |
rabbit hemorrhagic | 13 |
serum samples | 13 |
potential targets | 13 |
van der | 13 |
envelope glycoproteins | 13 |
final manuscript | 13 |
hcv infection | 13 |
mice treated | 13 |
acute hepatitis | 13 |
drug administration | 13 |
early stages | 13 |
mhc class | 13 |
pedv activity | 13 |
ifitm genes | 13 |
bimc assay | 12 |
cellular protein | 12 |
gene silencing | 12 |
recent advances | 12 |
host interactions | 12 |
molecular evolutionary | 12 |
luminex xtag | 12 |
increased risk | 12 |
proteins associated | 12 |
least three | 12 |
may help | 12 |
host receptors | 12 |
community acquired | 12 |
antiviral function | 12 |
basement membrane | 12 |
proteolytic processing | 12 |
data collection | 12 |
clinical presentation | 12 |
nucleocytoplasmic trafficking | 12 |
cellular proteomes | 12 |
signal peptidase | 12 |
tcid ml | 12 |
pmo targeting | 12 |
pregnant women | 12 |
antisense morpholino | 12 |
intracellular offspring | 12 |
network analysis | 12 |
stress response | 12 |
kidney cells | 12 |
tumor cell | 12 |
host antiviral | 12 |
terminal domain | 12 |
early stage | 12 |
orf gene | 12 |
pathogen panel | 12 |
mortality rates | 12 |
genomic analysis | 12 |
grouper iridovirus | 12 |
may play | 12 |
conjugated goat | 12 |
cohort study | 12 |
protein translation | 12 |
genetic elements | 12 |
data indicate | 12 |
ifn induction | 12 |
gene sequences | 12 |
heavy chain | 12 |
also reported | 12 |
protein spots | 12 |
cells incubated | 12 |
sequence information | 12 |
cell signaling | 12 |
kegg pathway | 12 |
clinical data | 12 |
cell growth | 12 |
obstructive pulmonary | 12 |
antiviral drug | 12 |
antiviral drugs | 12 |
maximum likelihood | 12 |
airway epithelial | 12 |
key role | 12 |
jak stat | 12 |
assessed using | 12 |
plant pathogens | 12 |
recent report | 12 |
highly variable | 12 |
strand rna | 12 |
biological replicates | 12 |
glossina pallidipes | 12 |
recently reported | 12 |
therapeutic potential | 12 |
control sequence | 12 |
two types | 12 |
antibody titers | 12 |
molecular weight | 12 |
gene products | 12 |
savannah river | 12 |
specific antibody | 12 |
process control | 12 |
considered statistically | 12 |
error bars | 12 |
cell responses | 12 |
oxygen species | 12 |
qlamp assay | 12 |
actin cytoskeleton | 12 |
specific control | 12 |
eta tt | 12 |
protein abundance | 12 |
antiviral activities | 12 |
highly contagious | 12 |
single nucleotide | 12 |
specific antibodies | 12 |
acute wheezing | 12 |
tumor necrosis | 12 |
metal resistance | 12 |
reading frames | 12 |
quantitative analysis | 12 |
type ii | 12 |
swab samples | 12 |
gpnmb expression | 12 |
necrosis factor | 12 |
reporter plasmid | 12 |
hev genome | 12 |
sgiv infection | 12 |
standard deviation | 12 |
oxidative stress | 12 |
infected animals | 12 |
ssrna viruses | 12 |
epi isl | 12 |
human polyclonal | 12 |
human populations | 12 |
protease activity | 12 |
drug discovery | 12 |
pcp domain | 12 |
tumor growth | 12 |
influenza viruses | 12 |
severe influenza | 11 |
genbank id | 11 |
stimulated gene | 11 |
length genome | 11 |
potential role | 11 |
pedv rna | 11 |
rabbit anti | 11 |
digesta samples | 11 |
santa cruz | 11 |
protein interaction | 11 |
orip binding | 11 |
protein ns | 11 |
binding affinity | 11 |
acute viral | 11 |
adenovirus species | 11 |
antiviral effect | 11 |
chronic infection | 11 |
coronavirus spike | 11 |
significantly decreased | 11 |
acid amplification | 11 |
herd immunity | 11 |
eif alpha | 11 |
protective effect | 11 |
primer sets | 11 |
heat shock | 11 |
alpha beta | 11 |
antibiotic resistome | 11 |
cleavage site | 11 |
clinical settings | 11 |
frequently detected | 11 |
igm repertoire | 11 |
risk hpv | 11 |
membrane dent | 11 |
infection may | 11 |
intraperitoneally injected | 11 |
van den | 11 |
porcine respiratory | 11 |
srs soils | 11 |
channel activity | 11 |
standard deviations | 11 |
hcv life | 11 |
hepg cells | 11 |
control rna | 11 |
time point | 11 |
membrane dents | 11 |
measured using | 11 |
many viruses | 11 |
results demonstrated | 11 |
charged region | 11 |
age groups | 11 |
strains belonging | 11 |
different lineages | 11 |
induced ifn | 11 |
lr phylo | 11 |
also revealed | 11 |
hev orf | 11 |
bovine beta | 11 |
class ii | 11 |
rdrp regions | 11 |
ppp group | 11 |
genome copies | 11 |
knockdown cells | 11 |
biological processes | 11 |
cell differentiation | 11 |
coronavirus infections | 11 |
nucleotide polymorphisms | 11 |
virus cell | 11 |
te mcat | 11 |
asthmatic patients | 11 |
inflammatory lung | 11 |
real time | 11 |
cells transfected | 11 |
st cells | 11 |
fluorescence signal | 11 |
emerging viruses | 11 |
allogeneic hct | 11 |
total number | 11 |
negatively charged | 11 |
tgev infected | 11 |
virus genomes | 11 |
endothelial cell | 11 |
similar results | 11 |
chronic obstructive | 11 |
per sample | 11 |
potential therapeutic | 11 |
fusion inhibitor | 11 |
first step | 11 |
causative agents | 11 |
hpv entry | 11 |
lactobacillus plantarum | 11 |
gene ontology | 11 |
rhinovirus species | 11 |
serum albumin | 11 |
hypertrophy virus | 11 |
cellular response | 11 |
male mice | 11 |
like structures | 11 |
disulfide bonds | 11 |
years old | 11 |
polymerase amplification | 11 |
nasopharyngeal microbiota | 11 |
current knowledge | 11 |
macrolide resistance | 11 |
significant increase | 11 |
several viruses | 11 |
ps infection | 11 |
copy numbers | 11 |
tested using | 11 |
human pathogens | 11 |
recombinase polymerase | 11 |
resistant genes | 11 |
acute inflammatory | 11 |
new coronavirus | 11 |
human pathogen | 11 |
emerging infectious | 11 |
retrospective study | 11 |
expressing gm | 11 |
zikv replication | 11 |
igf receptor | 11 |
atmuv replication | 11 |
closely associated | 11 |
authors read | 11 |
genomic sequences | 11 |
ml hg | 11 |
genetically engineered | 11 |
blood samples | 11 |
pcr positive | 11 |
roll fold | 11 |
hr domains | 11 |
gene therapy | 11 |
test results | 11 |
emcv infection | 11 |
growth response | 11 |
significantly lower | 11 |
viruses including | 11 |
puerto rico | 10 |
viral particle | 10 |
acquired respiratory | 10 |
liver tissue | 10 |
yeast two | 10 |
health problem | 10 |
infections caused | 10 |
dna vaccines | 10 |
logistic regression | 10 |
obtained using | 10 |
conserved among | 10 |
fmdv replication | 10 |
phage particle | 10 |
old piglets | 10 |
bone marrow | 10 |
rsv infections | 10 |
epidemiological study | 10 |
inducible factor | 10 |
linked glycosylation | 10 |
watery diarrhea | 10 |
wastewater treatment | 10 |
may contribute | 10 |
mediated cell | 10 |
major coat | 10 |
natural host | 10 |
may serve | 10 |
future research | 10 |
river site | 10 |
taxonomic assignment | 10 |
fold higher | 10 |
late endosomes | 10 |
microbiota profiles | 10 |
results indicate | 10 |
rich region | 10 |
hr peptides | 10 |
interferon regulatory | 10 |
sg proteome | 10 |
horizontal transfer | 10 |
xtag gpp | 10 |
pf malaria | 10 |
identified proteins | 10 |
human ace | 10 |
ebv genome | 10 |
human primates | 10 |
serum levels | 10 |
human hepatitis | 10 |
virus isolation | 10 |
recombination events | 10 |
expression cassette | 10 |
research question | 10 |
written informed | 10 |
entry receptor | 10 |
nuclear factor | 10 |
activation molecule | 10 |
within days | 10 |
molecular tests | 10 |
multiple functions | 10 |
igf group | 10 |
protein icp | 10 |
previously published | 10 |
four different | 10 |
sybr green | 10 |
recognition receptors | 10 |
throughput sequencing | 10 |
accession numbers | 10 |
antibiotic treatment | 10 |
hematologic malignancies | 10 |
influenza infection | 10 |
early growth | 10 |
detection limit | 10 |
associated pneumonia | 10 |
incubation period | 10 |
gene sequence | 10 |
dn ds | 10 |
virus genotype | 10 |
therapeutic strategies | 10 |
zoonotic viruses | 10 |
national center | 10 |
parainfluenza viruses | 10 |
fusion inhibitors | 10 |
bacterial co | 10 |
viral etiology | 10 |
hev particles | 10 |
pneumoniae cap | 10 |
target dna | 10 |
hepatocellular carcinoma | 10 |
genome assembly | 10 |
zikv strains | 10 |
engineered phage | 10 |
virus disease | 10 |
factor receptor | 10 |
family flaviviridae | 10 |
metapneumovirus infection | 10 |
disease caused | 10 |
soil habitat | 10 |
ifn pathway | 10 |
blot analysis | 10 |
staphylococcus aureus | 10 |
fluorescent protein | 10 |
control study | 10 |
sputum samples | 10 |
iii ifn | 10 |
body site | 10 |
three species | 10 |
cell lysates | 10 |
epidemiological studies | 10 |
healthy children | 10 |
adv infections | 10 |
central nervous | 10 |
therapeutic target | 10 |
acid sequences | 10 |
igm antibodies | 10 |
stat pathway | 10 |
working concentration | 10 |
reference genome | 10 |
high mortality | 10 |
intracellular trafficking | 10 |
natural hosts | 10 |
protease inhibitor | 10 |
transfection reagent | 10 |
five times | 10 |
dominant negative | 10 |
infected hela | 10 |
studies suggest | 10 |
play important | 10 |
oligonucleotide ligation | 10 |
ubiquitin ligases | 10 |
phosphorylated stat | 10 |
study also | 10 |
infectious virus | 10 |
mortality risk | 10 |
infection group | 10 |
acid sequence | 10 |
env proteins | 10 |
tumor virus | 10 |
risk factor | 10 |
studies using | 10 |
clinical outcomes | 10 |
copies per | 10 |
united kingdom | 10 |
lateral flow | 10 |
derived peptides | 10 |
bpv species | 10 |
ifn responses | 10 |
positive cells | 10 |
better understand | 10 |
major cause | 10 |
aerosolized ribavirin | 10 |
rhinovirus infections | 10 |
normal gs | 10 |
prophylactic effects | 10 |
virion release | 10 |
bacterial pneumonia | 10 |
specific primer | 10 |
qpcr assay | 10 |
shed light | 10 |
cypa overexpression | 10 |
via clathrin | 10 |
secondary structures | 10 |
lamp assay | 10 |
significantly inhibited | 10 |
remains unknown | 10 |
viral targets | 10 |
viral titer | 10 |
highly sensitive | 10 |
bacterial species | 10 |
glossina species | 10 |
newly synthesized | 10 |
food matrices | 10 |
transplant patients | 10 |
alveolar macrophages | 10 |
erad process | 9 |
endogenous retrovirus | 9 |
clinical course | 9 |
zikv rna | 9 |
respiratory coronavirus | 9 |
hypervariable region | 9 |
antiviral role | 9 |
two main | 9 |
herpes zoster | 9 |
limited number | 9 |
related fsfs | 9 |
pro domain | 9 |
big data | 9 |
transfected rk | 9 |
serratia spp | 9 |
kshv infection | 9 |
expression vector | 9 |
cells compared | 9 |
detect viral | 9 |
patients hospitalized | 9 |
trypan blue | 9 |
lytic replication | 9 |
risk assessment | 9 |
molecular basis | 9 |
presenting cells | 9 |
virology section | 9 |
inhibit viral | 9 |
broadly neutralizing | 9 |
may represent | 9 |
thank dr | 9 |
infected vero | 9 |
borne encephalitis | 9 |
atypical pneumonia | 9 |
difficile infection | 9 |
communityacquired pneumonia | 9 |
host protein | 9 |
allogeneic stem | 9 |
chronic diseases | 9 |
hcv ns | 9 |
signal transducer | 9 |
volume article | 9 |
phosphorodiamidate morpholino | 9 |
raw data | 9 |
cell survival | 9 |
statistical analyses | 9 |
cycle progression | 9 |
iii interferon | 9 |
hexon gene | 9 |
mutant virus | 9 |
will also | 9 |
herpes virus | 9 |
control measures | 9 |
nucleotide identity | 9 |
glycosylation site | 9 |
loading control | 9 |
tumor regression | 9 |
pulmonary syndrome | 9 |
rna interference | 9 |
ighv genes | 9 |
isgs expression | 9 |
animal husbandry | 9 |
murine coronavirus | 9 |
secretory pathway | 9 |
experimental infection | 9 |
cancer cell | 9 |
tyrosine kinase | 9 |
target sequences | 9 |
less effective | 9 |
blood circulation | 9 |
human endogenous | 9 |
cell adhesion | 9 |
kaposi sarcoma | 9 |
considered significant | 9 |
control groups | 9 |
clinical manifestations | 9 |
mulbsta score | 9 |
antimicrobial therapy | 9 |
upper panel | 9 |
marburg virus | 9 |
inhibitory concentration | 9 |
spike glycoprotein | 9 |
fusion occurs | 9 |
specific treatment | 9 |
protein assay | 9 |
two clinical | 9 |
based multiplex | 9 |
environmental serratia | 9 |
lasv hr | 9 |
temporal dynamics | 9 |
secondary metabolites | 9 |
study demonstrated | 9 |
necrosis virus | 9 |
rapid identification | 9 |
extracted using | 9 |
may result | 9 |
ph condition | 9 |
binding interface | 9 |
cell proteins | 9 |
infection models | 9 |
psap motif | 9 |
may induce | 9 |
ct findings | 9 |
natural infection | 9 |
adaptive traits | 9 |
future studies | 9 |
viral macro | 9 |
study shows | 9 |
light chain | 9 |
human hepatoma | 9 |
evolutionary history | 9 |
culture supernatant | 9 |
four major | 9 |
blood cells | 9 |
virome analysis | 9 |
virus binding | 9 |
pandemic influenza | 9 |
lfd assay | 9 |
analysis based | 9 |
host specificity | 9 |
peptide libraries | 9 |
investigate whether | 9 |
computational analysis | 9 |
eukaryotic initiation | 9 |
symptomatic patients | 9 |
reported previously | 9 |
bacteriophage ms | 9 |
neutralizing activity | 9 |
san diego | 9 |
one hand | 9 |
tcid assay | 9 |
hantavirus pulmonary | 9 |
climate seasons | 9 |
tumor samples | 9 |
negative results | 9 |
fatality rate | 9 |
hexon protein | 9 |
hepatitis virus | 9 |
virus particle | 9 |
care unit | 9 |
least two | 9 |
disease mechanisms | 9 |
rabbit igg | 9 |
field conditions | 9 |
ipd patients | 9 |
host interaction | 9 |
weight loss | 9 |
ifitm protein | 9 |
graphpad software | 9 |
serine threonine | 9 |
serially diluted | 9 |
anterior kidney | 9 |
infecting humans | 9 |
lassa fever | 9 |
increased mortality | 9 |
designed based | 9 |
read counts | 9 |
host response | 9 |
cytokine levels | 9 |
host species | 9 |
evaluated using | 9 |
mtt assay | 9 |
two major | 9 |
cell penetrating | 9 |
molecular probes | 9 |
resistant mycoplasma | 9 |
next generation | 9 |
high viral | 9 |
isolated using | 9 |
long noncoding | 9 |
leader protein | 9 |
interferon signaling | 9 |
cfus ml | 9 |
intestinal tract | 9 |
ex vivo | 9 |
mcp entry | 9 |
bacterial cells | 9 |
also increased | 9 |
specific protease | 9 |
antiviral antibodies | 9 |
hpv types | 9 |
newly identified | 9 |
study reported | 9 |
using graphpad | 9 |
unweighted unifrac | 9 |
alexa fluor | 9 |
protein interacts | 9 |
thoracic society | 9 |
rna helicase | 9 |
goose parvovirus | 9 |
liver cells | 9 |
ms bacteriophage | 9 |
experimentally infected | 9 |
virus titers | 9 |
syndrome caused | 9 |
cytokine expression | 9 |
related covs | 9 |
nonstructural proteins | 9 |
many studies | 9 |
actin filaments | 9 |
bacterial communities | 9 |
sg proteins | 9 |
reporter assay | 9 |
plc prf | 9 |
clostridium difficile | 9 |
tested positive | 9 |
leukemia virus | 9 |
ns proteins | 9 |
cellular component | 9 |
significantly associated | 9 |
fecal samples | 9 |
primary antibody | 9 |
scomber japonicus | 9 |
signal peptide | 9 |
binding proteins | 9 |
inflammatory responses | 9 |
bacillus anthracis | 9 |
fully understood | 9 |
immune reconstitution | 8 |
broad spectrum | 8 |
highly specific | 8 |
vaccine candidates | 8 |
post infection | 8 |
viruses belonging | 8 |
discovery rate | 8 |
ebna protein | 8 |
metapneumovirus infections | 8 |
antiviral defense | 8 |
climate change | 8 |
solid organ | 8 |
novel mammalian | 8 |
viral life | 8 |
prrsv lineages | 8 |
also associated | 8 |
insulin receptor | 8 |
penetrating peptides | 8 |
evolutionary dynamics | 8 |
dna damage | 8 |
current pandemic | 8 |
genomic characterization | 8 |
hr helices | 8 |
partially sequenced | 8 |
horizontal gene | 8 |
atlantic salmon | 8 |
rpv species | 8 |
lipid membrane | 8 |
salmonella typhimurium | 8 |
atypical bacteria | 8 |
lower airway | 8 |
molecular mechanism | 8 |
children hospitalized | 8 |
avian coronaviruses | 8 |
animal health | 8 |
viral pathogen | 8 |
glucose metabolism | 8 |
developing countries | 8 |
human population | 8 |
treatment strategies | 8 |
master mix | 8 |
assay using | 8 |
likelihood method | 8 |
microbiota composition | 8 |
like proteins | 8 |
zinc finger | 8 |
tm cells | 8 |
spf chicks | 8 |
genomic sequence | 8 |
reduce viral | 8 |
lung disease | 8 |
gp protein | 8 |
currently available | 8 |
expression patterns | 8 |
virus glycoprotein | 8 |
viral nucleic | 8 |
three biological | 8 |
study using | 8 |
seminiferous tubule | 8 |
infected children | 8 |
red blood | 8 |
lower panel | 8 |
receptor signaling | 8 |
negative charges | 8 |
phage fusion | 8 |
cardiovascular disease | 8 |
vertical transmission | 8 |
plasmid dna | 8 |
mutational analysis | 8 |
chub mackerel | 8 |
mouse monoclonal | 8 |
likely due | 8 |
hg resistance | 8 |
hev strain | 8 |
clinical outcome | 8 |
phase i | 8 |
viral panel | 8 |
viral components | 8 |
ms plps | 8 |
positively correlated | 8 |
inducible transmembrane | 8 |
positive patients | 8 |
guangxi province | 8 |
isg expression | 8 |
surface antigen | 8 |
detailed information | 8 |
alpha diversity | 8 |
safe working | 8 |
structural biology | 8 |
tbk phosphorylation | 8 |
kg sab | 8 |
protein level | 8 |
antibiotic resistant | 8 |
case fatality | 8 |
erad pathway | 8 |
armored rna | 8 |
differential expression | 8 |
corresponding author | 8 |
signaling lymphocyte | 8 |
deficient mice | 8 |
nile river | 8 |
virus research | 8 |
sar strain | 8 |
hrv infections | 8 |
following pr | 8 |
takes place | 8 |
porcine intestinal | 8 |
drop syndrome | 8 |
positive cases | 8 |
human rhinoviruses | 8 |
bacterial pathogen | 8 |
single copy | 8 |
chicken ifitm | 8 |
induce apoptosis | 8 |
green fluorescent | 8 |
family hepeviridae | 8 |
monkey kidney | 8 |
candidatus arthromitus | 8 |
three replicates | 8 |
replication cycle | 8 |
complex glycans | 8 |
functional analysis | 8 |
target protein | 8 |
washed twice | 8 |
relative expression | 8 |
bacterial load | 8 |
also inhibit | 8 |
therapeutic approaches | 8 |
cerebrospinal fluid | 8 |
somatic mutations | 8 |
sfb genomes | 8 |
prrsv infection | 8 |
murine norovirus | 8 |
evolutionary genetics | 8 |
pcr using | 8 |
previous report | 8 |
direct interaction | 8 |
host immunity | 8 |
avian hev | 8 |
substrate binding | 8 |
kshv rta | 8 |
signaling events | 8 |
sarcomaassociated herpesvirus | 8 |
evolutionary relationships | 8 |
viral diversity | 8 |
previously demonstrated | 8 |
type diabetes | 8 |
igf expression | 8 |
multiple respiratory | 8 |
factor alpha | 8 |
th cell | 8 |
acid extraction | 8 |
fusion peptide | 8 |
purifying selection | 8 |
plant growth | 8 |
commensal bacteria | 8 |
mini kit | 8 |
human body | 8 |
secreted ns | 8 |
lung epithelial | 8 |
dependent signaling | 8 |
blood flukes | 8 |
egr plasmids | 8 |
fruit bats | 8 |
scale bar | 8 |
envelope proteins | 8 |
vero cell | 8 |
correlated positively | 8 |
cells harboring | 8 |
penetrating peptide | 8 |
sterile pbs | 8 |
secondary infections | 8 |
ct method | 8 |
neuropathic pain | 8 |
raw reads | 8 |
coding gene | 8 |
genome encodes | 8 |
ip assay | 8 |
viral hepatitis | 8 |
hbga binding | 8 |
quantitative proteomic | 8 |
renal syndrome | 8 |
helicase domain | 8 |
like particle | 8 |
three groups | 8 |
genome analysis | 8 |
may allow | 8 |
also significantly | 8 |
cypa expression | 8 |
protein disulfide | 8 |
rna samples | 8 |
flying fox | 8 |
viral genomic | 8 |
interferon lambda | 8 |
conjugated pmo | 8 |
protein glycosylation | 8 |
evolutionary rates | 8 |
fluorescently labeled | 8 |
disulfide isomerase | 8 |
showed high | 8 |
hydrogen peroxide | 8 |
positive selective | 8 |
virus interacts | 8 |
density levels | 8 |
membrane proteins | 8 |
bacterial genera | 8 |
vp vp | 8 |
lymphocyte activation | 8 |
first time | 8 |
cause disease | 8 |
mice lacking | 8 |
viral species | 8 |
prolonged shedding | 8 |
may occur | 8 |
ar spread | 8 |
neonatal piglets | 8 |
viral populations | 8 |
bacterial infection | 8 |
samples collected | 8 |
subgenomic rna | 8 |
expression plasmids | 8 |
proinflammatory cytokines | 8 |
cell type | 8 |
culture methods | 8 |
ace receptor | 8 |
entry site | 8 |
recent reports | 8 |
constructed using | 8 |
repeated three | 8 |
proteins identified | 8 |
orf ab | 8 |
kda protein | 8 |
ex taq | 8 |
viral persistence | 8 |
ifitm restriction | 8 |
surface expression | 8 |
lb broth | 8 |
host responses | 8 |
life sciences | 8 |
infected chicks | 8 |
yersinia pestis | 8 |
dmem supplemented | 8 |
high specificity | 8 |
past years | 8 |
medical sciences | 8 |
tag sequence | 8 |
confocal microscopy | 8 |
using real | 8 |
retrotranscribing viruses | 8 |
haemorrhagic disease | 8 |
rabbit haemorrhagic | 8 |
also evaluated | 8 |
candida albicans | 8 |
infectious entry | 8 |
virus human | 8 |
another group | 8 |
cell tropism | 8 |
east asia | 8 |
human lung | 8 |
nc sirna | 8 |
rav positions | 8 |
significant reduction | 8 |
cell metabolic | 8 |
gene source | 8 |
recently emerged | 8 |
tracker orange | 8 |
cell tracker | 8 |
treated group | 8 |
spleen samples | 8 |
therapeutic drugs | 8 |
type system | 8 |
bat coronaviruses | 8 |
cytopathic effects | 8 |
animal species | 8 |
transmission electron | 8 |
weighted unifrac | 8 |
negative bacteria | 8 |
decreased significantly | 8 |
acute gastroenteritis | 8 |
like cells | 8 |
survival rate | 8 |
clinically relevant | 8 |
life cycles | 8 |
significantly upregulated | 8 |
cellular proliferation | 8 |
lymphocyte count | 8 |
primers used | 8 |
serine protease | 8 |
airway remodeling | 8 |
type lectin | 8 |
densitometric analysis | 8 |
also decreased | 8 |
article supplementary | 8 |
endemic areas | 8 |
pattern recognition | 8 |
van houten | 8 |
significantly altered | 8 |
north american | 8 |
high quality | 8 |
murine leukemia | 8 |
pathogen interactions | 8 |
airway inflammation | 8 |
per well | 8 |
immunocompromised patients | 8 |
immune modulation | 8 |
studies demonstrated | 8 |
cdna synthesis | 8 |
egr expression | 8 |
newcastle disease | 8 |
specific phage | 8 |
psvna titers | 8 |
natural killer | 8 |
start site | 8 |
cells seeded | 8 |
asthmatic subjects | 8 |
time quantitative | 8 |
escape ifn | 8 |
polyacrylamide gel | 7 |
sample collection | 7 |
genus pestivirus | 7 |
interaction network | 7 |
severe bronchiolitis | 7 |
human enterovirus | 7 |
one patient | 7 |
rodent species | 7 |
overexpressed cells | 7 |
red list | 7 |
protein complex | 7 |
protein structure | 7 |
virus inhibits | 7 |
infection status | 7 |
transcription polymerase | 7 |
expression system | 7 |
orf encodes | 7 |
fluorescent reporter | 7 |
clinical practice | 7 |
virus vaccine | 7 |
ns hexamer | 7 |
wild boar | 7 |
synthetic peptides | 7 |
still unknown | 7 |
indel strain | 7 |
fluorescence microscopy | 7 |
pf emp | 7 |
medicinal plants | 7 |
transmembrane domains | 7 |
prepared ms | 7 |
dead patients | 7 |
antigen presenting | 7 |
structure analysis | 7 |
mouse mammary | 7 |
protein forms | 7 |
bacterial diversity | 7 |
viruses detected | 7 |
ebv replication | 7 |
highly diverse | 7 |
scientific community | 7 |
medical research | 7 |
rna levels | 7 |
specific viral | 7 |
restriction factor | 7 |
duchenne muscular | 7 |
molecular methods | 7 |
pcr method | 7 |
realtime pcr | 7 |
molecular diagnosis | 7 |
indel pedv | 7 |
clinical utility | 7 |
worth mentioning | 7 |
viral rnas | 7 |
fixation test | 7 |
accessory proteins | 7 |
rhdv nsp | 7 |
cell cytoplasm | 7 |
also tested | 7 |
transcription unit | 7 |
human papilloma | 7 |
virus induces | 7 |
one representative | 7 |
long non | 7 |
different levels | 7 |
tandem mass | 7 |
egr knockdown | 7 |
lentiviruses expressing | 7 |
nucleolar proteins | 7 |
singapore grouper | 7 |
swine acute | 7 |
pedv strain | 7 |
virus assembly | 7 |
etiological agent | 7 |
lymphocyte counts | 7 |
rheumatoid arthritis | 7 |
dna binding | 7 |
structural characterization | 7 |
increased expression | 7 |
left panel | 7 |
bat genomes | 7 |
genome using | 7 |
phosphate buffered | 7 |
seeded onto | 7 |
rpoa gene | 7 |
microbiology virology | 7 |
hcv genome | 7 |
sample size | 7 |
well tolerated | 7 |
los santos | 7 |
potential use | 7 |
response element | 7 |
endocytotic pathway | 7 |
negative mutant | 7 |
pv sax | 7 |
species transmission | 7 |
beta production | 7 |
suppressed fmdv | 7 |
cells per | 7 |
treatment options | 7 |
genbank database | 7 |
young adults | 7 |
biotechnology information | 7 |
section materials | 7 |
alignment tool | 7 |
phosphate dehydrogenase | 7 |
viruses exploit | 7 |
analysis skills | 7 |
right panel | 7 |
deep sequencing | 7 |
treatment plants | 7 |
illumina sequencing | 7 |
cells ml | 7 |
huh cells | 7 |
fluorescence microscope | 7 |
severe clinical | 7 |
classical swine | 7 |
national research | 7 |
genome coverage | 7 |
virus genotypes | 7 |
cellular components | 7 |
various types | 7 |
signal inside | 7 |
four genotypes | 7 |
org article | 7 |
eaton agent | 7 |
detection rates | 7 |
beta interferon | 7 |
genotype hepatitis | 7 |
comparative genomics | 7 |
snp rs | 7 |
thunnus maccoyii | 7 |
venezuelan equine | 7 |
equal amounts | 7 |
premix ex | 7 |
respiratory pathogen | 7 |
proteins detected | 7 |
cell interactions | 7 |
microplate reader | 7 |
coding rnas | 7 |
study provides | 7 |
genetics analysis | 7 |
infections may | 7 |
interferon induction | 7 |
marine fish | 7 |
entry process | 7 |
protein binding | 7 |
gpc protein | 7 |
recombinant protein | 7 |
core associated | 7 |
ribavirin treatment | 7 |
green monkey | 7 |
ns protease | 7 |
pel cells | 7 |
aa residues | 7 |
sequencing reads | 7 |
lytic cycle | 7 |
isg genes | 7 |
icbi vigen | 7 |
viral translation | 7 |
closest taxonomic | 7 |
effective antiviral | 7 |
protein inhibits | 7 |
prd adenovirus | 7 |
muscular dystrophy | 7 |
rana box | 7 |
higher expression | 7 |
elisa kit | 7 |
human tumor | 7 |
fatty acids | 7 |
higher risk | 7 |
coronavirus infectious | 7 |
direct binding | 7 |
data show | 7 |
pneumococcal disease | 7 |
generation sequencers | 7 |
complement fixation | 7 |
extracellular supernatants | 7 |
fusion pores | 7 |
coding sequence | 7 |
also important | 7 |
cruise ship | 7 |
semliki forest | 7 |
pacific chub | 7 |
gastrointestinal pathogen | 7 |
porcine kidney | 7 |
also demonstrated | 7 |
viral strains | 7 |
common cause | 7 |
luminex xmap | 7 |
also used | 7 |
lipid droplets | 7 |
site year | 7 |
virus among | 7 |
predicted using | 7 |
family proteins | 7 |
response gene | 7 |
csa treatment | 7 |
scop relatives | 7 |
proteolytic cleavage | 7 |
protein phosphatase | 7 |
current status | 7 |
genetic variation | 7 |
persistent lcmv | 7 |
virion surface | 7 |
primary antibodies | 7 |
dimethyl sulfoxide | 7 |
gene annotation | 7 |
replication complex | 7 |
protease domain | 7 |
outer membrane | 7 |
treated zikv | 7 |
transmitted via | 7 |
escape mutants | 7 |
bacterial composition | 7 |
regulatory protein | 7 |
modified bovine | 7 |
rna copies | 7 |
high sensitivity | 7 |
risk groups | 7 |
aligned using | 7 |
infections among | 7 |
phylogenetic analyses | 7 |
invasive pneumococcal | 7 |
protein interactions | 7 |
hepatoma cell | 7 |
resistance determinants | 7 |
base pairs | 7 |
unfolded proteins | 7 |
acute exacerbations | 7 |
lipid metabolism | 7 |
disease pathogenesis | 7 |
results revealed | 7 |
using imagej | 7 |
assay formats | 7 |
tumor suppressor | 7 |
glycan structures | 7 |
subcellular distribution | 7 |
paired sera | 7 |
requires endocytosis | 7 |
heptad repeat | 7 |
immunoblot analysis | 7 |
high concentrations | 7 |
positive granules | 7 |
molecular function | 7 |
developed countries | 7 |
enteric viruses | 7 |
clinical significance | 7 |
read depth | 7 |
study revealed | 7 |
infection also | 7 |
immunofluorescence assay | 7 |
carcinoma cells | 7 |
indicated times | 7 |
strongly associated | 7 |
strains isolated | 7 |
coding regions | 7 |
studies indicate | 7 |
culture medium | 7 |
also suggested | 7 |
fatty acid | 7 |
rich domain | 7 |
tracheal epithelial | 7 |
yellowtail kingfish | 7 |
cycle arrest | 7 |
consensus sequence | 7 |
serological tests | 7 |
case studies | 7 |
protein alone | 7 |
mutant viruses | 7 |
protein folds | 7 |
syncytial viruses | 7 |
clinical use | 7 |
confirmed cases | 7 |
sequenced using | 7 |
technical assistance | 7 |
including influenza | 7 |
made available | 7 |
mammary tumor | 7 |
reverse transcribed | 7 |
wound healing | 7 |
genus alphacoronavirus | 7 |
sfb colonization | 7 |
common pathogens | 7 |
ms coat | 7 |
method using | 7 |
latent infection | 7 |
cell function | 7 |
mice infected | 7 |
fish mucosal | 7 |
contains two | 7 |
genotype database | 7 |
novel lncrnas | 7 |
french polynesia | 7 |
rna helicases | 7 |
chikungunya virus | 7 |
human viruses | 7 |
derived cells | 7 |
prevent zikv | 7 |
equine encephalitis | 7 |
pneumonia patients | 7 |
isolated rna | 7 |
median age | 7 |
geographical distribution | 7 |
antiviral compounds | 7 |
novel virus | 7 |
plex assay | 7 |
opportunistic pathogens | 7 |
human participants | 7 |
diagnostic tests | 7 |
clinical isolates | 7 |
untreated cells | 7 |
complement activation | 7 |
leuconostoc mesenteroides | 7 |
cells showed | 7 |
coding region | 7 |
dengue viruses | 7 |
lasv gpc | 7 |
river cruise | 7 |
daily average | 7 |
polarized epithelial | 7 |
atypical porcine | 7 |
ion channels | 7 |
authors reviewed | 7 |
ifn response | 7 |
postherpetic neuralgia | 7 |
may affect | 7 |
protein gene | 7 |
signaling cascade | 7 |
statistical software | 7 |
human ifitm | 7 |
novel host | 7 |
macro domains | 7 |
observational study | 7 |
hr peptide | 7 |
cypa depletion | 7 |
virus lower | 7 |
avian ifitm | 7 |
hydrophilic interactions | 7 |
protein activates | 7 |
np cd | 7 |
autophagosome formation | 7 |
cytokine responses | 7 |
elevated levels | 7 |
mouse models | 7 |
viral proliferation | 7 |
imagej software | 7 |
inhibit hpv | 7 |
takara bio | 7 |
individual health | 7 |
cardiovirus infection | 7 |
human milk | 7 |
apoptosis induced | 7 |
cellular membranes | 7 |
bat cov | 7 |
amplification assay | 7 |
health services | 7 |
allowed us | 7 |
endophytic actinomycetes | 7 |
vaccine development | 7 |
much higher | 7 |
molecular detection | 7 |
pteropus bat | 7 |
novel human | 7 |
standard curve | 7 |
induce ifn | 7 |
detection methods | 7 |
replication level | 7 |
intestinal epithelium | 7 |
severe pneumonia | 7 |
effusion lymphoma | 7 |
gc content | 7 |
illumina hiseq | 7 |
gfp expression | 7 |
result showed | 7 |
national institute | 7 |
orange dots | 7 |
rdrp region | 7 |
stool samples | 7 |
cards toxin | 7 |
infected human | 7 |
polyubiquitin chains | 7 |
magnetic beads | 7 |
cytokine production | 7 |
samples using | 7 |
nk cells | 7 |
mitochondrial dna | 7 |
genetic variability | 7 |
experiments indicate | 7 |
sirna targeting | 7 |
newborn piglets | 7 |
entry inhibitor | 7 |
diseases society | 7 |
bat sars | 7 |
false discovery | 7 |
relative abundance | 7 |
viruses associated | 7 |
vp gene | 7 |
cleavage sites | 7 |
pcr assays | 7 |
primer pairs | 7 |
survival time | 7 |
viral lineage | 7 |
different concentration | 7 |
com icbi | 7 |
biological significance | 7 |
economic impact | 7 |
phage dna | 7 |
hospital stay | 7 |
sm buffer | 7 |
pcr primers | 7 |
chronic hev | 7 |
previous work | 7 |
clostridioides difficile | 7 |
heat map | 7 |
serial dilutions | 7 |
cell plasma | 7 |
fold dilution | 7 |
adenovirus dna | 7 |
different ecosystems | 7 |
iucn red | 7 |
pcr detection | 7 |
related proteins | 7 |
recent research | 7 |
primary human | 7 |
neutralizing monoclonal | 7 |
ecoplates tm | 7 |
infection causes | 7 |
molecular characterization | 7 |
microbiome studies | 7 |
cellular functions | 7 |
poorly understood | 7 |
mechanical ventilation | 7 |
animal study | 7 |
net negative | 7 |
sindbis virus | 6 |
bronchoalveolar lavage | 6 |
acute lower | 6 |
bacterial dna | 6 |
major histocompatibility | 6 |
yunnan province | 6 |
mer operon | 6 |
bacterial culture | 6 |
cell epitopes | 6 |
modified eagle | 6 |
like symptoms | 6 |
study suggested | 6 |
microsphere surface | 6 |
antiviral protein | 6 |
infected male | 6 |
small number | 6 |
fusion proteins | 6 |
higher bacterial | 6 |
receptor recognition | 6 |
based drug | 6 |
hev pcp | 6 |
binding lectin | 6 |
critically ill | 6 |
nucleotide polymorphism | 6 |
trs motif | 6 |
matrix metalloproteinase | 6 |
control strategies | 6 |
higher proportion | 6 |
virus activates | 6 |
antibiotic consumption | 6 |
based assay | 6 |
different viral | 6 |
genus betacoronavirus | 6 |
mediated il | 6 |
material section | 6 |
applied hp | 6 |
alive patients | 6 |
vp coding | 6 |
using lipofectamine | 6 |
phosphorodiamidate linkages | 6 |
landscape phage | 6 |
sgivinfected cells | 6 |
different proteins | 6 |
primary effusion | 6 |
variation among | 6 |
persistently infected | 6 |
american type | 6 |
divergence times | 6 |
virus vp | 6 |
isolated strains | 6 |
economic development | 6 |
disease burden | 6 |
much less | 6 |
mev infection | 6 |
mainly causes | 6 |
genome evolution | 6 |
different viruses | 6 |
ypk possessed | 6 |
orf proteins | 6 |
virus production | 6 |
gene encoding | 6 |
plant species | 6 |
cecum tissue | 6 |
purified using | 6 |
side effects | 6 |
pam cells | 6 |
associated gene | 6 |
food animals | 6 |
two experiments | 6 |
fully human | 6 |
mshmp sequences | 6 |
immune function | 6 |
virus may | 6 |
microbiome samples | 6 |
antimicrobial agents | 6 |
isre luciferase | 6 |
parasite infection | 6 |
phage coat | 6 |
igf plays | 6 |
multiple viral | 6 |
late infection | 6 |
suckling piglets | 6 |
infection among | 6 |
science foundation | 6 |
step growth | 6 |
conducted using | 6 |
andmouth disease | 6 |
rhinolophus bats | 6 |
human embryonic | 6 |
phage particles | 6 |
viral disease | 6 |
healthy adults | 6 |
viral families | 6 |
quantified using | 6 |
crucial role | 6 |
immune status | 6 |
spectrum antiviral | 6 |
among others | 6 |
anal swab | 6 |
organ failure | 6 |
shock protein | 6 |
bronchial epithelial | 6 |
endemic regions | 6 |
multiple alignment | 6 |
lymphoid tissues | 6 |
clinical disease | 6 |
ribosomal rna | 6 |
amplification techniques | 6 |
potential risk | 6 |
malaria endemicity | 6 |
muscovy duck | 6 |
endogenous ifn | 6 |
mechanisms involved | 6 |
rhesus macaque | 6 |
ultrastructural localization | 6 |
high concentration | 6 |
using standard | 6 |
new viruses | 6 |
bioactive metabolites | 6 |
inhibitors targeting | 6 |
whether pedv | 6 |
nasopharyngeal swabs | 6 |
contact surfaces | 6 |
final version | 6 |
investigated whether | 6 |
future prospects | 6 |
study found | 6 |
intracellular signaling | 6 |
structural similarities | 6 |
cardicola forsteri | 6 |
evolutionary analyses | 6 |
pmo target | 6 |
drug repurposing | 6 |
downstream signaling | 6 |
nuclear pore | 6 |
two case | 6 |
displayed peptides | 6 |
commercial vaccines | 6 |
pharmajet stratis | 6 |
culture collection | 6 |
chlamydia pneumoniae | 6 |
recent evidence | 6 |
research council | 6 |
pathogens detected | 6 |
animal experiments | 6 |
cell contact | 6 |
kinase pkr | 6 |
protein may | 6 |
caenorhabditis elegans | 6 |
current work | 6 |
antiviral proteins | 6 |
using quantitative | 6 |